MeiraGTx Holdings plc (MGTX) insider buying and SEC filings
MeiraGTx Holdings plc · CIK 1735438
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$4.7M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 20, 2026 | Planned (10b5-1) | Richard Giroux (CFO) sold 56,000 shares at about $9.95 ($557K), marked as a 10b5-1 plan trade. Holdings down 6% to 852,530 shares. | SEC filing Filed Oct 20, 2026, 8:57 PM ET |
| Oct 6, 2026 | Planned (10b5-1) | Stuart Naylor (Chief Sci Ofcr, Ophthalmology) sold 27,659 shares at about $10.64 ($294K), marked as a 10b5-1 plan trade. Holdings down 4% to 613,187 shares. | SEC filing Filed Oct 6, 2026, 8:53 PM ET |
| Aug 18, 2026 | Planned (10b5-1) | Alexandria Forbes (CEO and Director) sold 62,000 shares at about $13.86 ($859K), marked as a 10b5-1 plan trade. Holdings down 4% to 1,325,695 shares. | SEC filing Filed Aug 18, 2026 |
| Jul 21, 2026 | Planned (10b5-1) | Richard Giroux (CFO) sold 56,000 shares at about $12.51 ($701K), marked as a 10b5-1 plan trade. Holdings down 6% to 908,530 shares. | SEC filing Filed Jul 21, 2026 |
| Jul 7, 2026 | Planned (10b5-1) | Stuart Naylor (Chief Sci Ofcr, Ophthalmology) sold 27,659 shares at about $14.80 ($409K), marked as a 10b5-1 plan trade. Holdings down 4% to 640,846 shares. | SEC filing Filed Jul 7, 2026 |
| May 19, 2026 | Planned (10b5-1) | Alexandria Forbes (CEO and Director) sold 62,000 shares at about $9.17 ($569K), marked as a 10b5-1 plan trade. Holdings down 4% to 1,387,695 shares. | SEC filing Filed May 19, 2026 |
| Apr 21, 2026 | Planned (10b5-1) | Richard Giroux (CFO) sold 56,000 shares at about $10.22 ($572K), marked as a 10b5-1 plan trade. Holdings down 5% to 971,530 shares. | SEC filing Filed Apr 21, 2026 |
| Apr 7, 2026 | Planned (10b5-1) | Stuart Naylor (Chief Dev. Officer) sold 27,661 shares at about $9.36 ($259K), marked as a 10b5-1 plan trade. Holdings down 4% to 668,505 shares. | SEC filing Filed Apr 7, 2026 |
| Mar 24, 2026 | Planned (10b5-1) | Alexandria Forbes (CEO and Director) sold 62,000 shares at about $7.41 ($459K), marked as a 10b5-1 plan trade. Holdings down 4% to 1,449,695 shares. | SEC filing Filed Mar 24, 2026 |
35 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow MGTX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.